Published on : Apr 04, 2017
Albany, New York, April 04, 2017: The 91-paged report analyzes the key trends, growth drivers, restraints, and opportunities in the global market for hybrid imaging. Hybrid imaging is the combination of two or more imaging technologies to form a single, novel, and more powerful form of imaging.
One of the most prominent growth drivers of the global hybrid imaging market is the increasing popularity of computed tomography (CT) and positron emission tomography (PET) hybrid imaging. The PET-CT is a medical imaging modality that is crucial in the early and accurate diagnosis of diseases and chronic conditions. Newer technologies such as precise measurement for assessing the nature and size of tumors, minimal movement of patients, and increase in the data storage capacities that facilitate tracking of tumors by oncologists are being preferred by consumers. The emergence of personalized medicine, reduction of exposure to radiation, and enhanced diagnostic accuracy are also boosting the growth of the market.
By application, the global market for hybrid imaging has been segmented into cardiology, orthopedics, and oncology. Of these, the oncology segment, by virtue of its key role in the detection and understanding of location molecules, is expected to surface to the fore over the forecast period. Based on type of product, PET or MRI, SPECT or CT, and PET or CT are the key segments covered in the report. In 2016, the PET-CT segment held a dominant share in the market and is likely to continue to do so. The growth of this segment can be attributed to cost-efficiency, technological advancements, and favorable reimbursements.
Click to get more details with TOC in a PDF Format: http://www.researchmoz.us/enquiry.php?type=S&repid=1027788
Based on geography, the global market for hybrid imaging has been segmented into Asia Pacific (APAC), Europe, the Middle East, and Africa (EMEA), and the Americas. The Americas held the largest share in 2016 and might retain their dominant position over the forecast period too. The presence of beneficial reimbursement facilities offered by the Centers for Medicare and Medicaid Services (CMS) across this region has been driving the growth of this market. Asia Pacific is a key market on account of its untapped opportunities. Increasing consumer awareness and growing healthcare infrastructures in countries such as China and India are fuelling the hybrid imaging market.
The global hybrid imaging market is characterized by intense competition. It is fragmented due to the presence of numerous market players, who are aggressively undertaking distribution partnerships, product development, and technological up-gradation. Some of the major players operating in the global market for hybrid imaging are Siemens Healthcare, GE Healthcare, Philips Healthcare, AGFA Healthcare, Mediso, CMR Naviscan, BC Technical, Roses Medical & Surgical Supply, IBA Molecular, FUJIFILM Holdings, Cardinal Health, Nordion, Sofie Biosciences, Carestream Health, Eczacibasi-Monrol Nuclear Products, RadioMedix, Cubresa, Mylin Medical, Photo Diagnostic Systems, and Toshiba Medical Systems.
To order report Call USA – Canada Toll Free: 866-997-4948 or send an email on firstname.lastname@example.org